相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Randomized, Double-Blind, Dose-Escalation Trial of Triptorelin for Ovary Protection in Childhood-Onset Systemic Lupus Erythematosus
Hermine I. Brunner et al.
ARTHRITIS & RHEUMATOLOGY (2015)
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC study
R. A. Furie et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Efficacy and safety of atacicept for prevention of flares in patients with moderate-to-severe systemic lupus erythematosus (SLE): 52-week data (APRIL-SLE randomised trial)
David Isenberg et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis
Toshitaka Kizawa et al.
MODERN RHEUMATOLOGY (2015)
The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE
L. Watson et al.
LUPUS (2015)
Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
Daniel J. Wallace et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
New insights into the pathogenesis and management of lupus in children
A. Midgley et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2014)
Methodology of clinical trials for rare diseases
Catrin Tudur Smith et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2014)
9th European Lupus Conference, Athens, Greece, April 23-26, 2014 Abstracts
[Anonymous]
LUPUS (2014)
Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy
R. Sakthiswary et al.
LUPUS (2014)
The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children
Annemarie Rosan Kreeftmeijer-Vegter et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Prolonged improvement of childhood onset systemic lupus erythematosus following systematic administration of rituximab and cyclophosphamide
Thomas J. A. Lehman et al.
PEDIATRIC RHEUMATOLOGY (2014)
Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors
Mark C. Genovese et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial
Robert Zimmer et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo-Controlled Trial
M. C. Genovese et al.
ARTHRITIS AND RHEUMATISM (2013)
Efficacy and Safety of Ocrelizumab in Active Proliferative Lupus Nephritis: Results From a Randomized, Double-Blind, Phase III Study
Eduardo F. Mysler et al.
ARTHRITIS AND RHEUMATISM (2013)
Sifalimumab, a Human AntiInterferon- Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2013)
Biologics in SLE: Towards new approaches
Ronald F. van Vollenhoven et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2013)
Challenges and opportunities in SLE clinical trials
Ronald F. van Vollenhoven
CURRENT OPINION IN RHEUMATOLOGY (2013)
Intravenous cyclophosphamide combined with steroids in pediatric onset severe lupus nephritis
Prayong Vachvanichsanong et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2013)
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
D. J. Wallace et al.
LUPUS (2013)
The development of genome-wide association studies and their application to complex diseases, including lupus
J. Bentham et al.
LUPUS (2013)
PReS-FINAL-2356: A comparison of the American college of rheumatology and the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus using data from the uk juvenile systemic lupus erythematosus cohort study
O Lloyd et al.
Pediatric Rheumatology (2013)
Adding to complexity: comorbidity in paediatric rheumatic disease
Eve M. D. Smith et al.
RHEUMATOLOGY (2013)
Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up
Daniel J. Wallace et al.
RHEUMATOLOGY (2013)
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus Results of a phase I, placebo-controlled, double-blind, dose-escalation study
Jacqueline M. McBride et al.
ARTHRITIS AND RHEUMATISM (2012)
First Appearance and Location of Catecholaminergic Cells During Experimental Arthritis and Elimination by Chemical Sympathectomy
Silvia Capellino et al.
ARTHRITIS AND RHEUMATISM (2012)
Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort
Louise Watson et al.
ARTHRITIS AND RHEUMATISM (2012)
Efficacy and Safety of Rituximab in Patients With Active Proliferative Lupus Nephritis The Lupus Nephritis Assessment With Rituximab Study
Brad H. Rovin et al.
ARTHRITIS AND RHEUMATISM (2012)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
The origin and properties of extracellular DNA: From PAMP to DAMP
David S. Pisetsky
CLINICAL IMMUNOLOGY (2012)
Efficacy of mycophenolate mofetil in adolescent patients with lupus nephritis: evidence from a two-phase, prospective randomized trial
R. Sundel et al.
LUPUS (2012)
Expression of Toll-like receptors and their detection of nuclear self-antigen leading to immune activation in JSLE
Angela Midgley et al.
RHEUMATOLOGY (2012)
Glucocorticoid use and abuse in SLE
Guillermo Ruiz-Irastorza et al.
RHEUMATOLOGY (2012)
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus
Rina Mina et al.
ARTHRITIS CARE & RESEARCH (2012)
Unmet medical needs in systemic lupus erythematosus
Aisha Lateef et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
Ellen M. Ginzler et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Biologic Differences Between Various Inhibitors of the BLyS/BAFF Pathway: Should We Expect Differences Between Belimumab and Other Inhibitors in Development?
William Stohl
CURRENT RHEUMATOLOGY REPORTS (2012)
Bone Health in Juvenile-Onset Systemic Lupus Erythematosus
Caroline Chang et al.
CURRENT RHEUMATOLOGY REVIEWS (2012)
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
G. K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
The Efficacy and Safety of Abatacept in Patients With Non-Life-Threatening Manifestations of Systemic Lupus Erythematosus Results of a Twelve-Month, Multicenter, Exploratory, Phase IIb, Randomized, Double-Blind, Placebo-Controlled Trial
J. T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
Gabor G. Illei et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
B Cell-Targeted Therapies for Systemic Lupus Erythematosus An Update on Clinical Trial Data
R. John Looney
DRUGS (2010)
Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come
L. T. Ford et al.
JOURNAL OF CLINICAL PATHOLOGY (2010)
T cells as therapeutic targets in SLE
Jose C. Crispin et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
THERAPY Hydroxychloroquine in SLE: old drug, new perspectives
Thomas Doerner
NATURE REVIEWS RHEUMATOLOGY (2010)
Prevalence and burden of pediatric-onset systemic lupus erythematosus
Sylvia Kamphuis et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
American College of Rheumatology 2010 Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Jennifer M. Grossman et al.
ARTHRITIS CARE & RESEARCH (2010)
Denosumab-Mediated Increase in Hand Bone Mineral Density Associated With Decreased Progression of Bone Erosion in Rheumatoid Arthritis Patients
A. Deodhar et al.
ARTHRITIS CARE & RESEARCH (2010)
An antibody against RANKL for the treatment of osteoporosis, inflammatory and malignant bone diseases
Eduardo Maldonado-Gonzales et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2010)
Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus
I. E. A. Hoffman et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The Role of Neutrophil Apoptosis in Juvenile-Onset Systemic Lupus Erythematosus
Angela Midgley et al.
ARTHRITIS AND RHEUMATISM (2009)
Protective Effect of Hydroxychloroquine on Renal Damage in Patients With Lupus Nephritis: LXV, Data From a Multiethnic US Cohort
Guillermo J. Pons-Estel et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Prednisone, Lupus Activity, and Permanent Organ Damage
Mae Thamer et al.
JOURNAL OF RHEUMATOLOGY (2009)
Ethnic Differences in Pediatric Systemic Lupus Erythematosus
Linda T. Hiraki et al.
JOURNAL OF RHEUMATOLOGY (2009)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Damage and mortality in a group of British patients with systemic lupus erythematosus followed up for over 10 years
Sharon A. Chambers et al.
RHEUMATOLOGY (2009)
B cell depletion therapy for 19 patients with refractory systemic lupus erythematosus
A. Podolskaya et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2008)
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2008)
Abetimus sodium for renal flare in systemic lupus erythematosus
Mario H. Cardiel et al.
ARTHRITIS AND RHEUMATISM (2008)
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2008)
Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus
Hermine I. Brunner et al.
ARTHRITIS AND RHEUMATISM (2008)
APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
Elodie Belnoue et al.
BLOOD (2008)
A modular analysis framework for blood genomics studies: Application to systemic lupus erythematosus
Damien Chaussabel et al.
IMMUNITY (2008)
Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: A longitudinal study
Linda T. Hiraki et al.
JOURNAL OF PEDIATRICS (2008)
Adolescent onset of lupus results in moire aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII)
L. B. Tucker et al.
LUPUS (2008)
Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform
Chaim O. Jacob et al.
ARTHRITIS AND RHEUMATISM (2007)
Depletion of B cells in murine lupus: Efficacy and resistance
Anupama Ahuja et al.
JOURNAL OF IMMUNOLOGY (2007)
The role myeloid dendritic cells play in the pathogenesis of systemic lupus erythematosus
Jose C. Crispin et al.
AUTOIMMUNITY REVIEWS (2007)
Common variable immunodeficiency in systemic lupus erythematosus
Monica Fernandez-Castro et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2007)
Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus
C. A. A. Silva et al.
LUPUS (2007)
Toll-like receptors and innate immune responses in systemic lupus erythematosus
Robert Lafyatis et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
Rituximab therapy for childhood-onset systemic lupus erythematosus
M. Willems et al.
JOURNAL OF PEDIATRICS (2006)
Relationship between damage accrual, disease flares and cumulative drug therapies in juvenile-onset systemic lupus erythematosus
M. Bandeira et al.
LUPUS (2006)
Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus
V Lilleby et al.
ARTHRITIS AND RHEUMATISM (2005)
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
DA Isenberg et al.
RHEUMATOLOGY (2005)
Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?
P Riboldi et al.
AUTOIMMUNITY (2005)
Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis
TJA Lehman et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage
N Ruperto et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2004)
What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities;: Nature vs. nurture) cohort?: Where are we heading?
AG Uribe et al.
AUTOIMMUNITY REVIEWS (2004)
Microarray analysis of interferon-regulated genes in SLE
MK Crow et al.
AUTOIMMUNITY (2003)
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
MR Arbuckle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus
AM Jacobi et al.
ARTHRITIS AND RHEUMATISM (2003)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis
DT Boumpas et al.
ARTHRITIS AND RHEUMATISM (2003)
Immunosuppressive therapy in lupus nephritis -: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide
FA Houssiau et al.
ARTHRITIS AND RHEUMATISM (2002)
Pathogenesis of lupus
K Oelke et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus
J Zhang et al.
JOURNAL OF IMMUNOLOGY (2001)
Survey of unlicensed and off label drug use in paediatric wards in European countries
S Conroy et al.
BRITISH MEDICAL JOURNAL (2000)
Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy
Z Blumenfeld et al.
LUPUS (2000)
分享论文
